BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Lilly’s Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)

  December 8, 2025

   · 

  19 min read
• Press Releases

  ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

  December 8, 2025

   · 

  9 min read
• Press Releases

  ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisaftoclax in Venetoclax–Exposed Patients with Myeloid Malignances

  December 8, 2025

   · 

  9 min read
• Press Releases

  At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

  December 8, 2025

   · 

  7 min read
• Press Releases

  HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China

  December 8, 2025

   · 

  7 min read
• Press Releases

  SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025

  December 8, 2025

   · 

  5 min read
• Press Releases

  CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

  December 8, 2025

   · 

  4 min read
• Press Releases

  Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

  December 8, 2025

   · 

  11 min read
• Press Releases

  CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies

  December 8, 2025

   · 

  7 min read
• Press Releases

  AsymBio Commences Commercial Operations at Fengxian Base, Strengthening Global Biopharmaceutical CDMO Capabilities

  December 8, 2025

   · 

  3 min read